Top Markets
Coin of the day
Clarity Pharmaceuticals Ltd Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltd

CU6
Peringkat dalam Saham #11775
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company,... Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company’s lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
Harga Saham
$1.77
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$660.45M
Perubahan (1 hari)
7.26%
Perubahan (1 tahun)
-9.15%
Negara
AU
Perdagangan Clarity Pharmaceuticals Ltd (CU6)

Kategori

Riwayat harga saham Clarity Pharmaceuticals Ltd (CU6)
Harga penutupan tertinggi: $1.83 pada 2026-08-01

Harga penutupan terendah: $1.06 pada 2021-08-01
Riwayat harga saham Clarity Pharmaceuticals Ltd dari 2021 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 4.14%
2025 -32.14%
2024 182.71%
2023 71.64%
2022 17.37%
2021 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$233.52 -4.71%
IE
$15.30 -23.07%
CN
$520.74 6.34%
CH
$164.39 -9.49%
CH
$2.30 -28.59%
CN